Company / SG&A per Share
AYTU BIOPHARMA, INC SG&A per Share History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$2.91
FY2025
5-year range
$1.13 / $14.84
FY2021-FY2025
Trend
-19.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has fluctuated over the past 10 years, ranging from $0.50 in FY2015 to $429.94 in FY2018.
Based on SEC 10-K filings.
2.91 in FY2025 with a 10-year CAGR of +19.2%.
Improved from $14.84 to $2.91 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +36.9%
- 5-Year CAGR
- +8.0%
- 10-Year CAGR
- +19.2%
Key checks
Key Insights
- In FY2025, sg&a per share decreased 19.5% year-over-year.
- Peak sg&a per share was recorded in FY2018.
- Lowest sg&a per share in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.91 | -19.5% |
| FY2024 | $3.62 | -75.6% |
| FY2023 | $14.84 | +1209.1% |
| FY2022 | $1.13 | -44.1% |
| FY2021 | $2.03 | +2.1% |
| FY2020 | $1.98 | -99.5% |
| FY2018 | $429.94 | +361.2% |
| FY2017 | $93.23 | +1200.6% |
| FY2016 | $7.17 | +1322.7% |
| FY2015 | $0.50 | +616.4% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026